Literature DB >> 18926032

The diagnosis and misdiagnosis of tuberculosis.

P D O Davies1, M Pai.   

Abstract

There are two worlds when it comes to the diagnosis of tuberculosis (TB). One world has only smear microscopy at its disposal. There may also be some radiological facilities, usually at the patients' expense. The other world has all modern techniques available, including culture, nucleic acid amplification, molecular diagnostics and sophisticated radiological techniques such as computed tomography and positron emission tomography scanning. The ability to diagnose or misdiagnose TB will vary across these two worlds. In this review, we provide an overview of clinical, radiological, molecular and immunological diagnosis of TB and highlight the common difficulties and pitfalls in TB diagnosis.

Entities:  

Mesh:

Year:  2008        PMID: 18926032

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  59 in total

1.  Diagnostic accuracy of Quantiferon TB test for patients with SLE and miliary tuberculosis.

Authors:  Mukaddes Tozlu; Umut Kalyoncu; Sehnaz Alp; Serhat Unal; Meral Calguneri
Journal:  Rheumatol Int       Date:  2009-06-04       Impact factor: 2.631

Review 2.  Economic challenges associated with tuberculosis diagnostic development.

Authors:  Colleen F Hanrahan; Maunank Shah
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2014-04-28       Impact factor: 2.217

Review 3.  Clinical immunology and multiplex biomarkers of human tuberculosis.

Authors:  Gerhard Walzl; Mariëlle C Haks; Simone A Joosten; Léanie Kleynhans; Katharina Ronacher; Tom H M Ottenhoff
Journal:  Cold Spring Harb Perspect Med       Date:  2014-12-04       Impact factor: 6.915

Review 4.  Toward a unified biosignature for tuberculosis.

Authors:  Jeroen Maertzdorf; Stefan H E Kaufmann; January Weiner
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-23       Impact factor: 6.915

5.  Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response.

Authors:  Toidi Adekambi; Chris C Ibegbu; Stephanie Cagle; Ameeta S Kalokhe; Yun F Wang; Yijuan Hu; Cheryl L Day; Susan M Ray; Jyothi Rengarajan
Journal:  J Clin Invest       Date:  2015-03-30       Impact factor: 14.808

Review 6.  Urine for the diagnosis of tuberculosis: current approaches, clinical applicability, and new developments.

Authors:  Jonathan Peter; Clare Green; Michael Hoelscher; Peter Mwaba; Alimuddin Zumla; Keertan Dheda
Journal:  Curr Opin Pulm Med       Date:  2010-05       Impact factor: 3.155

7.  Prospective cross-sectional evaluation of the small membrane filtration method for diagnosis of pulmonary tuberculosis.

Authors:  Edward Jones-López; Yukari C Manabe; Moises Palaci; Carol Kayiza; Derek Armstrong; Lydia Nakiyingi; Willy Ssengooba; Mary Gaeddert; Rachel Kubiak; Pedro Almeida Júnior; David Alland; Reynaldo Dietze; Moses Joloba; Jerrold J Ellner; Susan E Dorman
Journal:  J Clin Microbiol       Date:  2014-05-07       Impact factor: 5.948

8.  13[C]-urea breath test as a novel point-of-care biomarker for tuberculosis treatment and diagnosis.

Authors:  Mandeep S Jassal; Gueno G Nedeltchev; Jong-Hee Lee; Seong Won Choi; Viorel Atudorei; Zachary D Sharp; Vojo Deretic; Graham S Timmins; William R Bishai
Journal:  PLoS One       Date:  2010-08-27       Impact factor: 3.240

Review 9.  Point-of-care assays for tuberculosis: role of nanotechnology/microfluidics.

Authors:  ShuQi Wang; Fatih Inci; Gennaro De Libero; Amit Singhal; Utkan Demirci
Journal:  Biotechnol Adv       Date:  2013-01-26       Impact factor: 14.227

Review 10.  Advances in addressing technical challenges of point-of-care diagnostics in resource-limited settings.

Authors:  ShuQi Wang; Mark A Lifson; Fatih Inci; Li-Guo Liang; Ye-Feng Sheng; Utkan Demirci
Journal:  Expert Rev Mol Diagn       Date:  2016-02-24       Impact factor: 5.225

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.